Cargando…
Papillary Thyroid Cancer and a TERT Promotor Mutation-positive Paraganglioma in a Patient With a Germline SDHB Mutation
PURPOSE: About 40% of paragangliomas (PGL) are due to germline mutations in one of several susceptibility genes. These genes rarely predispose to other non-PGL tumors. Here, we describe and functionally characterize a germline SDHB mutation in a patient who developed a BRAF(V600E) mutation-positive...
Autores principales: | Alzahrani, Ali S, Alswailem, Meshael, Murugan, Avaniyapuram Kannan, Alghamdi, Balgees, Al-Hindi, Hindi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165429/ https://www.ncbi.nlm.nih.gov/pubmed/35673401 http://dx.doi.org/10.1210/jendso/bvac076 |
Ejemplares similares
-
How do BRAF(V600E) and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?
por: Mukhtar, Noha, et al.
Publicado: (2023) -
THU683 TERT Promoter Mutations, But Not BRAF(V600E)Mutation, Correlate With The American Thyroid Association And TNM Staging Systems And Predict Outcome Of Differentiated Thyroid Cancer
por: Mukhtar, Noha, et al.
Publicado: (2023) -
Thyroid Cancer, Neuroendocrine Tumor, Adrenal Adenoma, and Other Tumors in a Patient With a Germline PMS1 Mutation
por: Alghamdi, Balgees, et al.
Publicado: (2023) -
SAT631 EPAS1 Mutations In Three Adjacent Nucleotides Resulting In Different Phenotypes
por: Alswailem, Meshael, et al.
Publicado: (2023) -
Case Report: Severe Gonadal Dysgenesis Causing 46,XY Disorder of Sex Development Due to a Novel NR5A1 Variant
por: Alhamoudi, Kheloud M., et al.
Publicado: (2022)